Lara__Rodriguez's profile picture. Learn learn learn!

Fortunately, It never ends

           MD, PhD, Urological surgeon
 🇪🇸🇫🇷

Lara Rodríguez Sánchez

@Lara__Rodriguez

Learn learn learn! Fortunately, It never ends MD, PhD, Urological surgeon 🇪🇸🇫🇷

Lara Rodríguez Sánchez reposted

It is our pleasure to partner with the @ClinicaNavarra and the FTS to help support their fantastic meeting here in Madrid. @Endo_Society @RSanchez_Salas @DrRastinehad @urobianco

FocalSociety's tweet image. It is our pleasure to partner with the @ClinicaNavarra and the FTS to help support their fantastic meeting here in Madrid. @Endo_Society @RSanchez_Salas @DrRastinehad @urobianco
FocalSociety's tweet image. It is our pleasure to partner with the @ClinicaNavarra and the FTS to help support their fantastic meeting here in Madrid. @Endo_Society @RSanchez_Salas @DrRastinehad @urobianco
FocalSociety's tweet image. It is our pleasure to partner with the @ClinicaNavarra and the FTS to help support their fantastic meeting here in Madrid. @Endo_Society @RSanchez_Salas @DrRastinehad @urobianco
FocalSociety's tweet image. It is our pleasure to partner with the @ClinicaNavarra and the FTS to help support their fantastic meeting here in Madrid. @Endo_Society @RSanchez_Salas @DrRastinehad @urobianco

The Focal Meeting at @ClinicaNavarra is happening! Two full days entirely dedicated to focal therapy for PCa, taking place right here in Spain!🇪🇸💫@FocalSociety

Lara__Rodriguez's tweet image. The Focal Meeting at @ClinicaNavarra is happening! Two full days entirely dedicated to focal therapy for PCa, taking place right here in Spain!🇪🇸💫@FocalSociety

Lara Rodríguez Sánchez reposted

🚨Join our highly rated world class @ucl VIRTUAL 2 day MRI Masterclass Nov 21-22 2025🚨 For urologists, radiologists, nurses, scientists anywhere in the 🌎 who want hands on experience in using prostate MRI 4 diagnosis & treatment #UroSoMe Book NOW ucl.ac.uk/short-courses/… 1/n

veerukasi's tweet image. 🚨Join our highly rated world class @ucl VIRTUAL 2 day MRI Masterclass Nov 21-22 2025🚨

For urologists, radiologists, nurses, scientists anywhere in the 🌎 who want hands on experience in using prostate MRI 4 diagnosis & treatment #UroSoMe

Book NOW ucl.ac.uk/short-courses/… 1/n

Last “robotic” day before becoming a mum 🤖🤰 Bittersweet to step away for a while from urology, my job&passion🤓. But I’m filled with joy to start a new adventure with the most amazing person by my side, FQ ❤️ Huge thanks to my amazing @IMMontsouris team for all their support!

Lara__Rodriguez's tweet image. Last “robotic” day before becoming a mum 🤖🤰
Bittersweet to step away for a while from urology, my job&passion🤓. 
But I’m filled with joy to start a new adventure with the most amazing person by my side, FQ ❤️ 
Huge thanks to my amazing @IMMontsouris team for all their support!

Lara Rodríguez Sánchez reposted

No te pierdas el Curso Terapia Focal en Cáncer de Próstata en el Congreso CAU 2025 - Panamá🇵🇦 🗓️ Fecha: Jueves 09 de Octubre 2025 🕓 Hora: 17:30 horas 📍 Lugar: Salón 3 ¡Los esperamos! Consulta el programa en: caupanama2025.com/programa-cau @siupurol @spurol1965

CAU_URO's tweet image. No te pierdas el Curso Terapia Focal en Cáncer de Próstata en el Congreso CAU 2025 - Panamá🇵🇦
🗓️ Fecha: Jueves 09 de Octubre 2025
🕓 Hora: 17:30 horas
📍 Lugar: Salón 3 
¡Los esperamos!
Consulta el programa en: caupanama2025.com/programa-cau

@siupurol @spurol1965

Lara Rodríguez Sánchez reposted

📣 Los invitamos al Curso de Terapia Focal con Casos Clínicos en Cáncer de Próstata – CAU 2025 🇵🇦 Un encuentro con profesores internacionales y experiencias clínicas de vanguardia. 🗓️ ¡Nos vemos en Panamá! #CAU2025 #Urología #TerapiaFocal #CáncerDePróstata @FocalSociety

RSanchez_Salas's tweet image. 📣 Los invitamos al Curso de Terapia Focal con Casos Clínicos en Cáncer de Próstata – CAU 2025 🇵🇦 
Un encuentro con profesores internacionales y experiencias clínicas de vanguardia.

🗓️ ¡Nos vemos en Panamá!
#CAU2025 #Urología #TerapiaFocal #CáncerDePróstata @FocalSociety

Lara Rodríguez Sánchez reposted

⚠️Launching today! The inaugural Focal Therapy Society newsletter, "The Focal Point." focaltherapy.org/newsletter/ Articles from experts on focal therapy, including: Clinical trials updates Conference proceedings Case examples Advocacy updates History and future of the FTS

KaraWattsMD's tweet image. ⚠️Launching today!

The inaugural Focal Therapy Society newsletter, "The Focal Point."

focaltherapy.org/newsletter/

Articles from experts on focal therapy, including:
Clinical trials updates
Conference proceedings
Case examples
Advocacy updates
History and future of the FTS

Lara Rodríguez Sánchez reposted

Thrilled to share our new @BJUIjournal study! 📊 Quantifying Gleason pattern 4 via MRI & targeted biopsy predicts prostate cancer metastasis better than standard Gleason grading & risk scores. Precision matters in risk stratification. 🔗 doi.org/10.1111/bju.16… @VickersBiostats


Lara Rodríguez Sánchez reposted

We investigated whether MRI visibility predicts outcomes after focal therapy for prostate cancer. Our findings suggest that highly visible lesions on MRI are associated with worse oncologic outcomes—even after focal therapy. bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bc…

KanekoMasatomo's tweet image. We investigated whether MRI visibility predicts outcomes after focal therapy for prostate cancer.
Our findings suggest that highly visible lesions on MRI are associated with worse oncologic outcomes—even after focal therapy.
bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bc…

Thrilled to have our review published in @SIU_Journal, where we explore the current landscape of focal therapy techniques for PCa🧐! Grateful to the co-authors and the journal for this opportunity @FocalSociety @IMMontsouris


Lara Rodríguez Sánchez reposted

Our rising ⭐️fellow @rocioroltes taking on a grant at the @CanUrolAssoc meeting 2025 in Ottawa. Great presentation on the potential rol of #MicroUs on AS for PCa. @ExactImaging @InfoAeu @FocalSociety @cusm_muhc @mcgillu

RSanchez_Salas's tweet image. Our rising ⭐️fellow @rocioroltes taking on a grant at the @CanUrolAssoc meeting 2025 in Ottawa. Great presentation on the potential rol of #MicroUs on AS for PCa. @ExactImaging @InfoAeu @FocalSociety @cusm_muhc @mcgillu
RSanchez_Salas's tweet image. Our rising ⭐️fellow @rocioroltes taking on a grant at the @CanUrolAssoc meeting 2025 in Ottawa. Great presentation on the potential rol of #MicroUs on AS for PCa. @ExactImaging @InfoAeu @FocalSociety @cusm_muhc @mcgillu

Kicking off the #UROonco25 with some exciting Crossfires 🔥: ➡️ MRI first or still PSA for screening? ➡️ Systematic or perilesional, + targeted biopsies? ➡️ Active surveillance for ISUP 2 PCa? ➡️ Is lymph node dissection here to stay—forever?

Lara__Rodriguez's tweet image. Kicking off the #UROonco25 with some exciting Crossfires 🔥:
➡️ MRI first or still PSA for screening?
➡️ Systematic or perilesional, + targeted biopsies?
➡️ Active surveillance for ISUP 2 PCa?
➡️ Is lymph node dissection here to stay—forever?

Grupo español de Terapia Focal!! Enhorabuena por esta iniciativa! @InfoAeu

Lara__Rodriguez's tweet image. Grupo español de Terapia Focal!! Enhorabuena por esta iniciativa! @InfoAeu

🕒 ¡Cuenta atrás completada! El curso de Terapia Focal durante el Congreso Español de Urología en Cadiz ya está aquí! Un honor y una alegría poder compartirlo en casa🇪🇸 Preguntas, bienvenidas; debates, aún más🤓 La terapia focal ha llegado para quedarse! Gracias a la @InfoAeu

Lara__Rodriguez's tweet image. 🕒 ¡Cuenta atrás completada!
El curso de Terapia Focal durante el Congreso Español de Urología en Cadiz ya está aquí!
Un honor y una alegría poder compartirlo en casa🇪🇸
Preguntas, bienvenidas; debates, aún más🤓
La terapia focal ha llegado para quedarse!  
Gracias a la @InfoAeu
Lara__Rodriguez's tweet image. 🕒 ¡Cuenta atrás completada!
El curso de Terapia Focal durante el Congreso Español de Urología en Cadiz ya está aquí!
Un honor y una alegría poder compartirlo en casa🇪🇸
Preguntas, bienvenidas; debates, aún más🤓
La terapia focal ha llegado para quedarse!  
Gracias a la @InfoAeu

Lara Rodríguez Sánchez reposted

🚨New #UROwebinar! Join to explore the fundamentals of focal therapy (FT) in #PCa. Learn why: ✔️ Imaging is central—from diagnosis to follow-up ✔️Pt selection is key ✔️ Phase III trials & registries aim to solidify FT’s role in PCa care Register now 👇 webinars.uroweb.org/EAU/webinars/1…

UrowebESU's tweet image. 🚨New #UROwebinar! Join to explore the fundamentals of focal therapy (FT) in #PCa. Learn why:

✔️ Imaging is central—from diagnosis to follow-up
✔️Pt selection is key 
✔️ Phase III trials & registries aim to solidify FT’s role in PCa care

Register now 👇
webinars.uroweb.org/EAU/webinars/1…

Lara Rodríguez Sánchez reposted

Our burgeoning field needed true visionaries to gain its foundations. Proud to be honoring @ThomasPolascik for his tireless efforts to launch #focaltherapy from mere dreams and ideas to real life changing therapies for our patients. Thank you!

FocalSociety's tweet image. Our burgeoning field needed true visionaries to gain its foundations. Proud to be honoring @ThomasPolascik for his tireless efforts to launch #focaltherapy from mere dreams and ideas to real life changing therapies for our patients. Thank you!
FocalSociety's tweet image. Our burgeoning field needed true visionaries to gain its foundations. Proud to be honoring @ThomasPolascik for his tireless efforts to launch #focaltherapy from mere dreams and ideas to real life changing therapies for our patients. Thank you!

Just kicked off the Focal Therapy space in the Prostate International Forum at #AUA25! @Alice_YuMD Up next: @FocalSociety meeting, 10 am!

Lara__Rodriguez's tweet image. Just kicked off the Focal Therapy space in the Prostate International Forum at #AUA25! @Alice_YuMD Up next: @FocalSociety meeting, 10 am!

Lara Rodríguez Sánchez reposted

Great debate 🗣️ at #AUA25! @Lara__Rodriguez @LondonProstate1 @EdwardSchaeffer @tanejauroIs Is focal therapy the right fit for all intermediate-risk prostate cancer cases? 🩺 Read the written conference summary 📝 on UroToday✍️ by @chavarriagaj ➡️ bit.ly/4lPQzBs


Lara Rodríguez Sánchez reposted

State-of-the-Art lecture: #FocalTherapy in #ProstateCancer: Prime time or not time? Presented by @tanejauro @nyulangone. #AUA25 written coverage by @chavarriagaj @UofT > bit.ly/4cN9AAd @AmerUrological

urotoday's tweet image. State-of-the-Art lecture: #FocalTherapy in #ProstateCancer: Prime time or not time? Presented by @tanejauro @nyulangone. #AUA25 written coverage by @chavarriagaj @UofT > bit.ly/4cN9AAd @AmerUrological
urotoday's tweet image. State-of-the-Art lecture: #FocalTherapy in #ProstateCancer: Prime time or not time? Presented by @tanejauro @nyulangone. #AUA25 written coverage by @chavarriagaj @UofT > bit.ly/4cN9AAd @AmerUrological
urotoday's tweet image. State-of-the-Art lecture: #FocalTherapy in #ProstateCancer: Prime time or not time? Presented by @tanejauro @nyulangone. #AUA25 written coverage by @chavarriagaj @UofT > bit.ly/4cN9AAd @AmerUrological
urotoday's tweet image. State-of-the-Art lecture: #FocalTherapy in #ProstateCancer: Prime time or not time? Presented by @tanejauro @nyulangone. #AUA25 written coverage by @chavarriagaj @UofT > bit.ly/4cN9AAd @AmerUrological

Lara Rodríguez Sánchez reposted

#AUA25 kicks straight off with a thorny topic: do we really understand localised prostate cancer? Answer: clearly no! We can't even agree on our age-old risk strat criteria: •GG1, PSA 21, 150cc = High risk 🤔 •GG2 49% ≠ GG3 51% 😂 •GG4 2mm 100% 4 worse than GG2 12mm 40% 4🤦

LambAlastair's tweet image. #AUA25 kicks straight off with a thorny topic: do we really understand localised prostate cancer?

Answer: clearly no!

We can't even agree on our age-old risk strat criteria:
•GG1, PSA 21, 150cc = High risk 🤔
•GG2 49% ≠ GG3 51% 😂
•GG4 2mm 100% 4 worse than GG2 12mm 40% 4🤦
LambAlastair's tweet image. #AUA25 kicks straight off with a thorny topic: do we really understand localised prostate cancer?

Answer: clearly no!

We can't even agree on our age-old risk strat criteria:
•GG1, PSA 21, 150cc = High risk 🤔
•GG2 49% ≠ GG3 51% 😂
•GG4 2mm 100% 4 worse than GG2 12mm 40% 4🤦
LambAlastair's tweet image. #AUA25 kicks straight off with a thorny topic: do we really understand localised prostate cancer?

Answer: clearly no!

We can't even agree on our age-old risk strat criteria:
•GG1, PSA 21, 150cc = High risk 🤔
•GG2 49% ≠ GG3 51% 😂
•GG4 2mm 100% 4 worse than GG2 12mm 40% 4🤦
LambAlastair's tweet image. #AUA25 kicks straight off with a thorny topic: do we really understand localised prostate cancer?

Answer: clearly no!

We can't even agree on our age-old risk strat criteria:
•GG1, PSA 21, 150cc = High risk 🤔
•GG2 49% ≠ GG3 51% 😂
•GG4 2mm 100% 4 worse than GG2 12mm 40% 4🤦

Loading...

Something went wrong.


Something went wrong.